Anti-angiogenic effects of imatinib target smooth muscle cells but not endothelial cells

Angiogenesis

Volumn 10, Issue 4, 2007, Pages 279-286

  Rocha, Ana ^a   Azevedo, Isabel ^a   Soares, Raquel ^a  

^a University of Porto   (Portugal)

Author keywords

Angiogenesis; Apoptosis; Cell growth; Imatinib; Migration; PDGF; Progesterone; Tyrosine kinase

Indexed keywords

BROXURIDINE; IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROGESTERONE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; BLOTTING, WESTERN; ENDOTHELIUM, VASCULAR; HUMANS; IN SITU NICK-END LABELING; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PIPERAZINES; PYRIMIDINES;

EID: 35748951584     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-007-9080-2     Document Type: Article

References (36)

1. Alvarez RH, Kantarjian HM, Cortes JE (2006) Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81(9):1241-1257
2. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/Pericyte interactions. Circ Res 97:512-523
3. Ault P (2007) Overview of second-generation tyrosine kinase inhibitors for patients with imatinib-resistant chronic myelogenous leukemia. Clin J Oncol Nurs 11:125-129
4. Buchdunger E, O'Reilly T, Wood J (2002) Pharmacology of Imatinib (STI571). Eur J Cancer 38(5):S28-S36
5. Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F (2005) Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res 7(5):R788-R795
6. Chan P (2002) Developments in restenosis. J Renin Angiotensin Aldosterone Syst 3:145-149
7. Chelouche D, Kim SJ, Onn A, Stone V, Nam DH, Yazici S, Fidler IJ, Price JE (2005) Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. Clin Cancer Res 11:306-314
8. Distler JW, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47:149-161
9. Edelberg JM, Lee SH, Kaur M, Tang L, Feirt NM, McCabe S, Bramwell O, Wong SC, Hong MK (2002) Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation 105(5):608-613
10. Faivre EJ, Lange CA (2007) Progesterone receptors up-regulate Wnt-1 to induce EGFR transactivation and c-Src dependent sustained activation of Erk1/2 MAP kinase in breast cancer cells. Mol Cell Biol 27(2):466-480
11. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273-286
12. George D (2001) Platelet-derived growth factor receptors: a therapeutic target in solid tumors. Semin Oncol 28(5 Suppl 17):27-33
13. Hyder SM (2006) Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endocr relat Cancer 13:667-687
14. Hyder SM, Chiappetta C, Stancel GM (2001) Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int J Cancer 92(4):469-473
15. Jones RL, Judson IR (2005) The development and application of imatinib. Expert Opin Drug Saf 4(2):183-191
16. Kantarjian HM, Cortes J (2006) New strategies in chronic myeloid leukemia. Int J Hematol 83(4):289-293
17. Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T (2005) Chemosensitization by STI571 targeting the platelet-derived growth factor/Platelet-derived growth factor receptor-signaling pathway in the tumour progression and angiogenesis of gastric carcinoma. Cancer 103(9):1800-1809
18. Kim SJ, Uehara H, Yazici S, Busby JE, Nakamura T, He J, Maya M, Logothetis C, Mathew P, Wang X, Do KA, Fan D, Fidler I (2006) Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate ccancer. J Natl Cancer Inst 98(11):783-793
19. Kvasnicka HM, Thiele J, Staib P, Schmitt-Graeff A, Griesshammer M, Klose J, Engels K, Kriener S (2004) Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI571) therapy. Blood 103(9):3549-3551
20. Liang Y, Hyder SM (2005) Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects. Endocrinology 146(8):3632-3641
21. Machens HG, Morgan JR, Berthiaume F, Stefanovich P, Siemers F, Krapohl B, Berger A, Mailander P (2002) Platelet-derived growth factor-AA-mediated functional angiogenesis in the rat epigastric island flap after genetic modification of fibroblasts is ischemia dependent. Surgery 131(4):393-400
22. Mauro MJ, Druker BJ (2001) STI571: targeting BCR-ABL as therapy for CML. Oncologist 6(3):233-238
23. Mirkin S, Navarro F, Archer DF (2003) Hormone therapy and endometrial angiogenesis. Climacteric 6(4):273-277
24. Nakamura Y, Suzuki T, Inoue T, Tazawa C, Ono K, Moriya T, Saito H, Ishibashi T, Takahashi S, Yamada S, Sasano H (2005) Progesterone receptor subtypes in vascular smooth muscle cells of human aorta. Endocr J 52(2):245-252
25. Ostman A (2004) PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15:275-286
26. Panigrahi I, Naithani R (2006) Imatinib mesylate: a designer drug. J Assoc Physicians India 54:203-206
27. Qin C, Liu Z (2007) In atherogenesis, the apoptosis of endothelial cell itself could directly induce over-proliferation of smooth muscle cells. Med Hypotheses 68:275-277
28. Radford IR (2002) Imatinib. Novartis. Curr Opin Investig Drugs 3(3):492-499
29. Rocha A, Azevedo I, Soares R (2007) Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects. J Cell Biochem (in press) (ISSN: 1097-4644)
30. Soares R, Guerreiro S, Botelho M (2007) Elucidating progesterone effects in breast cancer: cross talk with PDGF signalling pathway in smooth muscle cells. J Cell Biochem 100:174-183
31. Tallquist M, Kazlauskas A (2004) PDGF signaling in cells and mice. Cytokine Growth Factor Rev 15(4):205-213
32. Taylor C (2000) Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor. Endocrinology 141:1545-1553
33. Tsutsumi N, Yonemitsu Y, Shikada Y, Onimaru M, Tanii M, Okano S, Kaneko K, Hasegawa M, Hashizume M, Maehara Y, Sueishi K (2004) Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis. Circ Res 94(9):1186-1194
34. Tuveson DA, Willis NA, Jacks T, Griffin JD, Singer S, Fletcher CD, Fletcher JA, Demetri GD (2001) STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene 20(36):5054-5058
35. Walter LM, Rogers PAW, Girling JE (2005) The role of progesterone in endometrial angiogenesis in pregnant and ovariectomised mice. Reproduction 129:765-777
36. Wu J, Richer J, Horwitz KB, Hyder SM (2004) Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. Cancer Res 64(6):2238-2244